Edesa Biotech Inc.

NASDAQ: EDSA · Real-Time Price · USD
2.24
-0.02 (-0.88%)
At close: Aug 15, 2025, 3:59 PM
2.23
-0.22%
After-hours: Aug 15, 2025, 04:04 PM EDT

Edesa Biotech Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a -1.12M n/a n/a 1.12M n/a n/a n/a n/a -3.51M n/a n/a n/a
Cost of Revenue
25.79K 24.51K 43.11K n/a 51.41K 45.4K 45.03K 45.97K 83K 27.3K 27.2K 28.96K 29.59K 29.88K 29.75K 28.93K 31.21K 29.8K n/a
Gross Profit
-25.79K -24.51K -43.11K n/a -51.41K -45.4K -45.03K -1.16M -83K -27.3K 1.09M -28.96K -29.59K -29.88K -29.75K -3.54M -31.21K -29.8K n/a
Operating Income
-1.9M -1.64M -1.9M -1M -1.93M -2.22M -1.86M -2.37M -2.06M -2.41M -2.38M -2.84M -5.8M -4.58M -5.16M -5.48M -6.07M -9.51M -2.61M
Interest Income
572.00 265.00 1.67K 16.49K 32.85K 43.19K 60.97K 71.94K 82.75K 85.72K 49.43K 36.14K 17.52K 3.75K 6.12K 6.89K 2.61K 747.00 922.00
Pretax Income
-1.75M -1.59M -1.62M -962.05K -1.67M -1.86M -1.68M -1.72M -1.98M -2.33M -2.33M -2.81M -5.79M -4.57M -4.38M -3.69M -4.76M -2.26M -2.64M
Net Income
-1.75M -1.59M -1.62M -962.05K -1.67M -1.86M -1.68M -1.72M -1.98M -2.33M -2.29M -2.79M -5.77M -4.57M -4.38M -3.69M -4.76M -2.26M -2.64M
Selling & General & Admin
964.68K 1.15M 878.87K 900.53K 1.04M 998.74K 1.11M 1.42M 1.04M 952.39K 1.02M 1.04M 1.25M 1.53M 1.21M 1.36M 1.61M 1.54M 1.23M
Research & Development
939.07K 484.31K 1.02M 103.87K 897.3K 1.18M 704.46K 953.4K 1.03M 1.46M 1.36M 1.79M 4.55M 3.04M 3.95M 4.13M 4.46M 7.98M 1.38M
Other Expenses
n/a n/a n/a n/a n/a 14.77K n/a -43.49K n/a n/a 43.49K n/a n/a n/a n/a -80.78K n/a 80.78K n/a
Operating Expenses
1.9M 1.64M 1.9M 1M 1.93M 2.18M 1.81M 1.79M 2.06M 2.41M 2.38M 2.84M 5.8M 4.58M 4.38M 3.62M 4.77M 2.34M 2.61M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a -45.4K -45.03K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.9M 1.64M 1.9M 1M 1.93M 2.22M 1.86M 1.79M 2.06M 2.41M 2.38M 2.84M 5.8M 4.58M 4.38M 3.62M 4.77M 2.34M 2.61M
Income Tax Expense
n/a 800.00 n/a n/a n/a 800.00 n/a n/a n/a 800.00 -43.49K -22.4K -17.52K 800.00 -2.79K -800 -6.27K 800.00 23.81K
Shares Outstanding (Basic)
7.02M 5.31M 3.35M 3.2M 3.22M 3.19M 3.13M 3.03M 2.93M 2.85M 2.63M 2.29M 2.21M 1.98M 1.91M 1.9M 1.89M 1.66M 1.47M
Shares Outstanding (Diluted)
7.02M 5.31M 3.35M 3.2M 3.22M 3.19M 3.13M 3.03M 2.93M 2.85M 2.63M 2.29M 2.21M 1.98M 1.91M 1.9M 1.89M 1.66M 1.47M
EPS (Basic)
-0.25 -0.3 -0.48 -0.3 -0.52 -0.58 -0.54 -0.57 -0.68 -0.82 -0.87 -1.22 -2.61 -2.31 -2.3 -1.95 -2.51 -1.36 -1.8
EPS (Diluted)
-0.25 -0.3 -0.48 -0.3 -0.52 -0.58 -0.54 -0.57 -0.68 -0.82 -0.87 -1.22 -2.61 -2.31 -2.3 -1.94 -2.51 -1.36 -1.8
EBITDA
-1.69M -1.64M -1.57M -917.84K -1.62M -1.82M -1.63M -1.67M -1.98M -2.38M -2.35M -2.78M -5.77M -4.55M -4.35M -3.66M -4.73M -2.23M -2.58M
EBIT
-1.72M -1.59M -1.62M -962.05K -1.67M -1.92M -1.74M -1.72M -2.06M -2.41M -2.38M -2.84M -5.8M -4.58M -4.38M -3.62M -4.76M -2.26M -2.61M
Depreciation & Amortization
25.79K 24.51K 43.11K 44.21K 51.41K 45.4K 45.03K 45.97K 83K 27.3K 27.2K 28.96K 29.59K 29.88K 29.75K 28.93K 31.21K 29.8K 28.84K